title: [Use of intravenous immunoglobulin in treatment of neoplasms and hematologic disorders in children].
abstract: Immunoglobulins are an important component of the immune system and of the host defense against infection. They are also important in immune regulation. The intravenous immunoglobulins has been proven beneficial in prophylaxis and treatment of infections in patients with primary and secondary immunodeficiency. Many studies confirmed the efficacy of IVIG in the treatment of idiopathic thrombocytopenic purpura and other autoimmune disorders. In the last years monoclonal antibodies were included to anticancer therapy in children and adults.
authors.affiliation: Katedra i Klinika Onkologii i Hematologii Dzieciecej Akademii Medycznej we Wrocławiu.
authors.forename: Grazyna
authors.initials: G
authors.lastname: Wróbel
authors.forename: Alicja
authors.initials: A
authors.lastname: Chybicka
authors.forename: Bernarda
authors.initials: B
authors.lastname: Kazanowska
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy; D002648:Child; D015658:HIV Infections / Q000150:complications; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D009894:Opportunistic Infections / Q000188:drug therapy / Q000276:immunology; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy
chemical_list: D016756:Immunoglobulins, Intravenous